MALAT1 and osteosarcoma: In terms of MALAT1, a study suggested that high MALAT1 expression is also associated with advanced clinicopathological features as well as poor prognosis in osteosarcoma (54), which might emerge as potential therapeutic targets in the treatment of patients with osteosarcoma.